Deep learning to estimate impaired glucose metabolism from Magnetic Resonance Imaging of the liver: An opportunistic population screening approach.


Journal

PLOS digital health
ISSN: 2767-3170
Titre abrégé: PLOS Digit Health
Pays: United States
ID NLM: 9918335064206676

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 15 07 2023
accepted: 07 12 2023
medline: 16 1 2024
pubmed: 16 1 2024
entrez: 16 1 2024
Statut: epublish

Résumé

Diabetes is a global health challenge, and many individuals are undiagnosed and not aware of their increased risk of morbidity/mortality although dedicated tests are available, which indicates the need for novel population-wide screening approaches. Here, we developed a deep learning pipeline for opportunistic screening of impaired glucose metabolism using routine magnetic resonance imaging (MRI) of the liver and tested its prognostic value in a general population setting. In this retrospective study a fully automatic deep learning pipeline was developed to quantify liver shape features on routine MR imaging using data from a prospective population study. Subsequently, the association between liver shape features and impaired glucose metabolism was investigated in individuals with prediabetes, type 2 diabetes and healthy controls without prior cardiovascular diseases. K-medoids clustering (3 clusters) with a dissimilarity matrix based on Euclidean distance and ordinal regression was used to assess the association between liver shape features and glycaemic status. The deep learning pipeline showed a high performance for liver shape analysis with a mean Dice score of 97.0±0.01. Out of 339 included individuals (mean age 56.3±9.1 years; males 58.1%), 79 (23.3%) and 46 (13.6%) were classified as having prediabetes and type 2 diabetes, respectively. Individuals in the high risk cluster using all liver shape features (n = 14) had a 2.4 fold increased risk of impaired glucose metabolism after adjustment for cardiometabolic risk factors (age, sex, BMI, total cholesterol, alcohol consumption, hypertension, smoking and hepatic steatosis; OR 2.44 [95% CI 1.12-5.38]; p = 0.03). Based on individual shape features, the strongest association was found between liver volume and impaired glucose metabolism after adjustment for the same risk factors (OR 1.97 [1.38-2.85]; p<0.001). Deep learning can estimate impaired glucose metabolism on routine liver MRI independent of cardiometabolic risk factors and hepatic steatosis.

Identifiants

pubmed: 38227569
doi: 10.1371/journal.pdig.0000429
pii: PDIG-D-23-00265
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000429

Informations de copyright

Copyright: © 2024 Michel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Lea J Michel (LJ)

Department of Diagnostic and Interventional Radiology, University Hospital Freiburg, Freiburg, Germany.

Susanne Rospleszcz (S)

Department of Epidemiology, Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.
Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
German Center for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany.

Marco Reisert (M)

Medical Physics, Department of Radiology, Medical Center-University of Freiburg, Freiburg, Germany.

Alexander Rau (A)

Department of Diagnostic and Interventional Radiology, University Hospital Freiburg, Freiburg, Germany.

Johanna Nattenmueller (J)

Department of Diagnostic and Interventional Radiology, University Hospital Freiburg, Freiburg, Germany.

Wolfgang Rathmann (W)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; German Center for Diabetes Research, München-Neuherberg, Germany.

Christopher L Schlett (CL)

Department of Diagnostic and Interventional Radiology, University Hospital Freiburg, Freiburg, Germany.

Annette Peters (A)

Department of Epidemiology, Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.
Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
German Center for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Germany.
German Center for Diabetes Research (DZD), partner site Neuherberg, Neuherberg, Germany.

Fabian Bamberg (F)

Department of Diagnostic and Interventional Radiology, University Hospital Freiburg, Freiburg, Germany.

Jakob Weiss (J)

Department of Diagnostic and Interventional Radiology, University Hospital Freiburg, Freiburg, Germany.

Classifications MeSH